Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis

Documenti analoghi

• Efficacy and field safety of ilunocitinib for the control of atopic dermatitis in client‐owned dogs: A multicentre, double‐masked, randomised, placebo‐controlled clinical trial
  di: Sophie Forster, et al.
  Pubblicazione: (2025)
• Efficacy and Field Safety of Ilunocitinib for the Control of Allergic Dermatitis in Client‐Owned Dogs: A Multicenter, Double‐Masked, Randomised, Placebo‐Controlled Clinical Trial
  di: Sophie Forster, et al.
  Pubblicazione: (2025)
• Evaluation of oclacitinib maleate and prednisolone combined therapy for the control of atopic dermatitis in dogs: A controlled clinical trial
  di: Tássia Sell Ferreira, et al.
  Pubblicazione: (2025)
• Evaluation of filaggrin 2 expression in dogs with atopic dermatitis before and after oclacitinib maleate administration
  di: Wendie Roldan Villalobos, et al.
  Pubblicazione: (2025)
• Prevalence and lesion distribution of atopic dermatitis in small‐to‐medium breed dogs in Korea
  di: Ji‐Hye Ryu, et al.
  Pubblicazione: (2025)